Bangladesh
5 years ago

Libra Infusion's share price jumps 29pc

The company recommends 20pc stock dividend

Published :

Updated :

Share price of Libra Infusion jumped more than 29 per cent following the news that the company recommended 20 per cent stock dividend for the year ended on June 30, 2018.

The pharma & chemicals sector company's share traded between Tk 750 and Tk 950, before closing at Tk 925.50 each. The company's share price rose more than Tk 209 each on Monday.

The company's share price hovered between Tk 480 and Tk 1,334.80 each in the last one year.

The board of directors of the company has recommended 20 per cent stock dividend for the year ended on June 30, 2018, according to an official disclosure on Monday.

The final approval of dividend will come during the annual general meeting (AGM) scheduled to be held on December 22 in Dhaka.

The record date of the company is on November 20.

The company has also reported earnings per share (EPS) of Tk 5.01, net asset (NAV) per share of Tk 1,593.00 and net operating cash flow per share (NOCFPS) of Tk 3.39 for the year ended on June 30, 2018 as against Tk 4.86, Tk 1,578.00 and Tk 1.75 respectively for the same period of the previous year.

Libra Infusion, which was listed on the Dhaka Stock Exchange (DSE) in 1994, disbursed 30 per cent cash dividend last year.

The company's paid-up capital is Tk 12.52 million and authorised capital is Tk 100 million, while the total number of securities is 1.25 million.

The sponsor-directors own 34.43 per cent stake in the company while the institutional investors own 13.86 per cent and the general public 51.71 per cent as on September 30, 2018, the DSE data shows.

Intech was the day's second highest gainer, posting a gain of 22.30 per cent to close at Tk 47.70 each, followed by Fine Foods 17 per cent to close at Tk 38.40, Deshbandhu Polymer 14 per cent to close at Tk 16 each, Fu-Wang Foods 12 per cent to close at Tk 14.70 each as there was no price limited of their shares trading due to corporate declarations.

[email protected]

Share this news